Literature DB >> 24364635

Outpatient management of alcohol withdrawal syndrome.

Herbert L Muncie1, Yasmin Yasinian2, Linda Oge'1.   

Abstract

Approximately 2% to 9% of patients seen in a family physician's office have alcohol dependence. These patients are at risk of developing alcohol withdrawal syndrome if they abruptly abstain from alcohol use. Alcohol withdrawal syndrome begins six to 24 hours after the last intake of alcohol, and the signs and symptoms include tremors, agitation, nausea, sweating, vomiting, hallucinations, insomnia, tachycardia, hypertension, delirium, and seizures. Treatment aims to minimize symptoms, prevent complications, and facilitate continued abstinence from alcohol. Patients with mild or moderate alcohol withdrawal syndrome can be treated as outpatients, which minimizes expense and allows for less interruption of work and family life. Patients with severe symptoms or who are at high risk of complications should receive inpatient treatment. In addition to supportive therapy, benzodiazepines, either in a fixed-dose or symptom-triggered schedule, are recommended. Medication should be given at the onset of symptoms and continued until symptoms subside. Other medications, including carbamazepine, oxcarbazepine, valproic acid, and gabapentin, have less abuse potential but do not prevent seizures. Typically, physicians should see these patients daily until symptoms subside. Although effective treatment is an initial step in recovery, long-term success depends on facilitating the patient's entry into ongoing treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24364635

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

Review 1.  Identification and management of alcohol withdrawal syndrome.

Authors:  Antonio Mirijello; Cristina D'Angelo; Anna Ferrulli; Gabriele Vassallo; Mariangela Antonelli; Fabio Caputo; Lorenzo Leggio; Antonio Gasbarrini; Giovanni Addolorato
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

Review 2.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

3.  Thiamine in the management of alcohol use disorders.

Authors:  Shima Shakory
Journal:  Can Fam Physician       Date:  2020-03       Impact factor: 3.275

4.  Behavioral characterization of withdrawal following chronic voluntary ethanol consumption via intermittent two-bottle choice points to different susceptibility categories.

Authors:  Natalia A Quijano Cardé; Mariella De Biasi
Journal:  Alcohol Clin Exp Res       Date:  2022-02-15       Impact factor: 3.928

5.  Is medical treatment of Alcohol Withdrawal Syndrome a Stag Hunt? Challenges and opportunities in managing risk and uncertainty in addiction cessation.

Authors:  Roger Lee Mendoza
Journal:  Risk Manag Healthc Policy       Date:  2017-12-21

Review 6.  A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review).

Authors:  Simona Trifu; Andrian Țîbîrnă; Radu-Virgil Costea; Alexandra Popescu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

7.  Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents.

Authors:  Corinde E Wiers; Leandro F Vendruscolo; Jan-Willem van der Veen; Peter Manza; Ehsan Shokri-Kojori; Danielle S Kroll; Dana E Feldman; Katherine L McPherson; Catherine L Biesecker; Rui Zhang; Kimberly Herman; Sophie K Elvig; Janaina C M Vendruscolo; Sara A Turner; Shanna Yang; Melanie Schwandt; Dardo Tomasi; Mackenzie C Cervenka; Anders Fink-Jensen; Helene Benveniste; Nancy Diazgranados; Gene-Jack Wang; George F Koob; Nora D Volkow
Journal:  Sci Adv       Date:  2021-04-09       Impact factor: 14.136

Review 8.  Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies.

Authors:  Claire Shyu; Sofia Chavez; Isabelle Boileau; Bernard Le Foll
Journal:  Brain Sci       Date:  2022-07-13

Review 9.  Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.

Authors:  Jessica L Taylor; Samantha Johnson; Ricardo Cruz; Jessica R Gray; Davida Schiff; Sarah M Bagley
Journal:  J Gen Intern Med       Date:  2021-06-22       Impact factor: 5.128

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.